ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 752879 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 752879; 2) Community: the network communities that were significantly associated with the response to NSC 752879; 3) Molecule: the relationships between components within communities and NSC 752879; 4) MDR: the compounds that were significantly associated with the NSC 752879.

NSC Compound Enrichment Correlation
NSC 718781 Erlotinib hydrochloride 0.0366216145653011 0.23289506
NSC 726217 Combretastatin A4-analogue 0.0366216145653011 -0.43748425
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.0366216145653011 -0.26081458
NSC 752506 5-nitro-N-((pyridin-3-yl)methyl)furan-2-carboxamide 0.0366216145653011 -0.098863842
NSC 753456 2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole 0.0366216145653013 -0.1685096
NSC 761832 (Z)-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one 0.0366216145653013 -0.28624375
NSC 762346 Null 0.0366216145653013 -0.24786412
NSC 93819 Depakine 0.0366216145653013 0.10640803
NSC 712572 1,2 Benzo-8-(1-hydroxy-2-methylamino propane)-3-phenoxazone 0.0366216145653016 -0.099163777
NSC 12455 Acid Alizarin Red B 0.038689522570041 -0.1834787
Total:62  Current:46    [First] [Prev] [Next] [Last]